238 related articles for article (PubMed ID: 7482539)
1. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
2. The effects of diquat and ciprofibrate on mRNA expression and catalytic activities of hepatic xenobiotic metabolizing and antioxidant enzymes in rat liver.
Gallagher EP; Buetler TM; Stapleton PL; Wang C; Stahl DL; Eaton DL
Toxicol Appl Pharmacol; 1995 Sep; 134(1):81-91. PubMed ID: 7676460
[TBL] [Abstract][Full Text] [Related]
3. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.
McLellan LI; Judah DJ; Neal GE; Hayes JD
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):117-24. PubMed ID: 8198522
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE
Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168
[TBL] [Abstract][Full Text] [Related]
5. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
6. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
7. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.
Waxman DJ; Sundseth SS; Srivastava PK; Lapenson DP
Cancer Res; 1992 Oct; 52(20):5797-802. PubMed ID: 1394205
[TBL] [Abstract][Full Text] [Related]
9. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone.
Lamb JG; Franklin MR
Drug Metab Dispos; 2000 Sep; 28(9):1018-23. PubMed ID: 10950843
[TBL] [Abstract][Full Text] [Related]
10. Hepatic glutathione S-transferases in mice fed on a diet containing the anticarcinogenic antioxidant butylated hydroxyanisole. Isolation of mouse glutathione S-transferase heterodimers by gradient elution of the glutathione-Sepharose affinity matrix.
Hayes JD; Kerr LA; Peacock SD; Cronshaw AD; McLellan LI
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):501-12. PubMed ID: 1859377
[TBL] [Abstract][Full Text] [Related]
11. Oltipraz is a bifunctional inducer activating both phase I and phase II drug-metabolizing enzymes via the xenobiotic responsive element.
Miao W; Hu L; Kandouz M; Batist G
Mol Pharmacol; 2003 Aug; 64(2):346-54. PubMed ID: 12869639
[TBL] [Abstract][Full Text] [Related]
12. Induction of drug metabolizing enzymes by 1,7-phenanthroline and oltipraz in mice is unrelated to Ah-responsiveness.
Carr BA; Franklin MR
J Biochem Mol Toxicol; 1999; 13(2):77-82. PubMed ID: 9890192
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiation-inducible hepatic glutathione-S-transferases Ya, Yb1, Yb2, Yc1, and Yc2 gene expression by oltipraz: possible role in radioprotection.
Kim SG; Nam SY; Kim CW; Kim JH; Cho CK; Yoo SY
Mol Pharmacol; 1997 Feb; 51(2):225-33. PubMed ID: 9203627
[TBL] [Abstract][Full Text] [Related]
14. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways.
Johnson DR; Klaassen CD
Toxicol Sci; 2002 Jun; 67(2):182-9. PubMed ID: 12011477
[TBL] [Abstract][Full Text] [Related]
15. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin.
Hayes JD; Chanas SA; Henderson CJ; McMahon M; Sun C; Moffat GJ; Wolf CR; Yamamoto M
Biochem Soc Trans; 2000 Feb; 28(2):33-41. PubMed ID: 10816095
[TBL] [Abstract][Full Text] [Related]
16. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
17. Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
Begleiter A; Sivananthan K; Curphey TJ; Bird RP
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):566-72. PubMed ID: 12815004
[TBL] [Abstract][Full Text] [Related]
18. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.
Hayes JD; Judah DJ; McLellan LI; Kerr LA; Peacock SD; Neal GE
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):385-98. PubMed ID: 1953636
[TBL] [Abstract][Full Text] [Related]
19. Differences in induction by xenobiotics in murine tissues and the Hepa1c1c7 cell line of mRNAs encoding glutathione transferase, quinone reductase, and CYP1A P450s.
Sisk SC; Pearson WR
Pharmacogenetics; 1993 Aug; 3(4):167-81. PubMed ID: 8220436
[TBL] [Abstract][Full Text] [Related]
20. Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response element.
Lubet RA; Yao R; Grubbs CJ; You M; Wang Y
Chem Biol Interact; 2009 Nov; 182(1):22-8. PubMed ID: 19695238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
